Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic Review

被引:0
|
作者
Gossec, Laure [1 ,2 ]
Bessette, Louis [3 ]
Xavier, Ricardo M. [4 ]
Favalli, Ennio G. [5 ,6 ]
Ostor, Andrew [7 ,8 ,9 ]
Buch, Maya H. [10 ,11 ]
机构
[1] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM, Paris, France
[2] Hop La Pitie Salpetriere, Paris, France
[3] Laval Univ, Quebec City, PQ, Canada
[4] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, Brazil
[5] Univ Milan, Milan, Italy
[6] ASST G Pini CTO Inst, Milan, Italy
[7] Monash Univ, Melbourne, Vic, Australia
[8] Australian Natl Univ, Canberra, NSW, Australia
[9] Emeritus Res, Melbourne, Vic, Australia
[10] Univ Manchester, Manchester, England
[11] NIHR Manchester Biomed Res Ctr, Manchester, England
关键词
SHARED DECISION-MAKING; DISEASE-ACTIVITY; MEDICATION ADHERENCE; PATIENT PREFERENCES; CONTROLLED-TRIAL; SELF-ASSESSMENT; MANAGEMENT; RECOMMENDATIONS; EDUCATION; RHEUMATOLOGISTS;
D O I
10.1002/acr.25408
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTreat-to-target is recommended in the management of rheumatoid arthritis (RA) but its implementation is suboptimal. We aimed to identify interventional strategies targeted at improving treat-to-target implementation in RA by systematically reviewing published evidence on barriers to, facilitators of, and interventions to support treat-to-target implementation.MethodsSystematic and scoping literature searches in PubMed/MEDLINE, BIOSIS Previews, Derwent Drug File, Embase, EMCare, International Pharmaceutical Abstracts, and SciSearch were conducted to identify barriers/facilitators and interventions relating to treat-to-target implementation in RA. The quality of included studies was assessed using Critical Appraisal Skills Programme (CASP) checklists. Data related to barriers/facilitators and interventions were extracted, grouped, and summarized descriptively, and a narrative synthesis was generated.ResultsIn total, 146 articles were analyzed, of which 123 (84%) included >= 50% of the items assessed by CASP checklists. Of the 146 studies, 76 evaluated treat-to-target barriers and facilitators, from which 329 relevant statements were identified and regrouped into 18 target areas, including health care professional (HCP) or patient knowledge or perceptions; patient-HCP communication or alignment; and time or resources. Overall, 56 interventions were identified from 70 studies across the 18 target areas; 54% addressed disease activity or patient-reported outcome assessments. Of the 56 interventions identified, 36 improved treat-to-target implementation and/or patient outcomes in RA.ConclusionDespite long-established treat-to-target recommendations, there remain many barriers to its implementation. Interventions to improve treat-to-target should be developed further and assessed, with a particular focus on tailoring them to individual countries, regions, and health care settings.
引用
收藏
页码:1626 / 1636
页数:11
相关论文
共 50 条
  • [1] IMPROVING TREAT-TO-TARGET IMPLEMENTATION IN RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW OF BARRIERS, FACILITATORS, AND INTERVENTIONS
    Gossec, L.
    Bessette, L.
    Xavier, R.
    Favalli, E. G.
    Ostor, A.
    Buch, M. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 572 - 572
  • [2] Barriers and facilitators to application of treat-to-target management in psoriatic arthritis and axial spondyloarthritis in practice: A systematic literature review
    Webers, Casper
    Essers, Ivette
    Been, Marin
    van Tubergen, Astrid
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
  • [3] BARRIERS AND FACILITATORS TO APPLICATION OF TREAT-TO-TARGET MANAGEMENT IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS IN PRACTICE: A SYSTEMATIC LITERATURE REVIEW
    Webers, C.
    Essers, I
    Been, M.
    Van Tubergen, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 92 - 93
  • [4] Treat-to-target in rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (04): : E208 - E208
  • [5] Treat-to-Target Strategies in Rheumatoid Arthritis
    van der Hem-van Mil, Annette H. M.
    Huizinga, Tom W. J.
    Bloem, Johan L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (01): : 83 - 83
  • [6] Treat-to-Target Strategies in Rheumatoid Arthritis: a Systematic Review and Cost-Effectiveness Analysis
    Emma Stefania Hock
    Marrissa Martyn-St James
    Allan Wailoo
    David L. Scott
    Matt Stevenson
    Andrew Rawdin
    Emma L. Simpson
    Naila Dracup
    Adam Young
    SN Comprehensive Clinical Medicine, 2021, 3 (3) : 838 - 854
  • [7] Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions
    José A. Sacristán
    Silvia Díaz
    Inmaculada de la Torre
    José Inciarte-Mundo
    Alejandro Balsa
    Rheumatology and Therapy, 2019, 6 : 473 - 477
  • [8] Treat-to-target in rheumatoid arthritis — are we there yet?
    Ronald van Vollenhoven
    Nature Reviews Rheumatology, 2019, 15 : 180 - 186
  • [9] Treat-to-target in rheumatoid arthritis - are we there yet?
    van Vollenhoven, Ronald
    NATURE REVIEWS RHEUMATOLOGY, 2019, 15 (03) : 180 - 186
  • [10] Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions
    Sacristan, Jose A.
    Diaz, Silvia
    de la Torre, Inmaculada
    Inciarte-Mundo, Jose
    Balsa, Alejandro
    RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 473 - 477